AR 226 _ 3272 ; Co MRA2E_ 3492 -_-- ofvre TRADE SECRET Study Tike H-25914: Static, Acute, 48-Hour `Toxicity Screening Test with Daphnia magna AUTHORS: Laurie D.

#601 --_ ~ @ ~ AR226- 3429 33 000272 | ARAR6 = 3429 D> EXPOSURE ASSESSMENT PROTOCOL Work RequestNo.: Service Code No.: Performing Institution: Study Title: 15076 1361 Haskell Laboratory for Health and Environmental Sciences OEcxtpaonsouirceAAcsisdeAsnsimoenntinotfhMeeMaasnuurfeadctSuerreuomf APemrmflounoiriunmated Perfluorooctanoate (APFO) at Fayetteville, NC | | |Ji 3), | 2) || | | | || Study Director: Coinvestigators: SJeonsieoprhIFn.duVsitsrkioaolilH,ygJir.enCiIsHt H1a0s9k0elEllkLtaobnorRaotaodry for Health and Environmental Sciences Newark, DE 191714 S Hh-- e-- ------ Robin C.

1v2{lf Pp > i - ARRIE _ 34-50 54 000433 ree ] - E. 1.

------ 1371 Ps ~ { Pp EE -- AR2_324765 i 7 000728 | | Tlomres fluors Dosages sanguins +UVislilneerssdSeaJnatrPrae,ulPierre Baite, + EOHS, PNA,PFOA,PFOS +dPrcelmvbermeen2t0s0e1f,fjecatniviseenrt fvrier2002 +LaboratoireShiwara(Bremen, D) comms ARRRE IIS | o i 000729 Produitsdoss: +EOH8 `perfluorooctylethanol CsFi7CH2CH20H + PFNA perfluorononanoic `acid CsFI7COO + PFOA perfluorooctanoic acid C1F15000 PFOS pecfluorooctylsulfonate CsF17803. || 8 2 000730 , TM & F 7 \ po v agaga | ~B - 000731 ~ | |] | Lo] OS 4 00073, . | | ts st a rat se efixcpaossetlepsoturmloeinPsFdOiAff(itraeunxt5fois rieu, maisplusde30foisinfrieauuir esl3eMpleufsb2a0s0dfooisseicnhferzileeursop3lraavtaeluerusr. ls publiepar 3M quiest5000ppb) : difnefstpassrignieficantivecpouerle ,etprobapbasnloneplmspoeurnlePtF ch{e 81d'seplaaslimritdeedetqeucatntification) PFaleOAU,SleAs :tporumroPinFssOoSncteausonnitvealuapfoopiusllaers| 4 o , 000733 . : Pa PFOA Comparaisons des .

Date: 20 September 2023 Universal PFAS Restriction and Sorafenib Possible Consequences of a PFAS REACH restriction on medicinal products - Sorafenib as one example out of many potentially impacted active pharmaceutical ingredients (API) Background Five national competent authorities (Germany, the Netherlands, Norway, Sweden and Denmark) have submitted an annex XV dossier under EU REACH on the restriction of per- and polyfluoroalkyl substances (PFAS) in January 2023 to ECHA.

me 2930524 ReviDsiuopnoNnutm1b4e1r621 TRADE SECRET AR2RG. 3583 Study Title PFO (L1i4n-eDaary/BOrraanlchGeadv)a,gAePSFtOud(yLiinneMara)l,eaRnadtsAPanFdOM(iBcreanched): AUTHOR: Carol Finlay, B.A.

p. 1 n1 Q C*t Cll( llz< -E--+ %*0Cf)cuCU U C: ccu- ~ Ca 0 L.

8/15/00 LPSD Water Sample Analytical Results (Letter, R.

Annex1_List of the functions and properties necessary to electrical and electronic equipment (EEE), which need PFAS materials to attain required performances.

EXHIBIT A p. 2 36qq TM rrv,, .., . ,. " .

B~~fQ - 1006- j 65"9e oUPONT D Pu ont Haskell Laboratory for Health and Environmental Sciences Elkton Road, P .O .

2nd submission - Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

Betreft: reactie op het pfas-restrictievoorstel Datum: 24 september 2023 Over VNCI De Koninklijke Vereniging van de Nederlandse Chemische Industrie (VNCI) is de brancheorganisatie voor de chemische industrie in Nederland.

p. 1 73 March 7, DuPont Chemical Solutions Enterprise P . 0 .

P. z z6 -37773 ~~- PFOA : A 96-HOUR STATIC-RENEWAL ACUTE TOXICITY TEST WITH Chironomus tentans AMENDED FINAL REPOR T WILDLIFE INTERNATIONAL, LTD .